Clin2
NCT07086755Possibly a fitRecruiting

Vadadustat treatment for lung injury from infection

Nonintubated Acute Respiratory Distress Syndrome (ARDS)Pathogen-associated Lung Injury

Treatments studied

Part of Lungs & breathing clinical trials.

This trial tests a pill called vadadustat for people with a serious lung condition called ARDS, which makes it hard to breathe. The drug may reduce inflammation and improve oxygen levels, helping patients recover without needing a breathing tube.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
1,100 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have lung injury caused by an infection like pneumonia or another infection in the body.
  • You have low oxygen levels despite using a high-flow oxygen mask or a breathing machine (but not a breathing tube).
  • Your breathing problem started or got worse within the last week.
  • Your chest X-ray or ultrasound shows new fluid or inflammation in the lungs.
  • You are not currently on medications that could interfere, and you have no serious liver or blood problems.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06703073Recruiting· Phase 2
Testing new treatments for acute respiratory distress syndrome (ARDS)

This trial is testing new treatments for people with ARDS, a serious lung condition. The goal is to find therapies that help patients breathe better and recover faster. If you or a loved one has ARDS, this study may offer access to experimental treatments.

Birmingham, Alabama
NCT07208591Recruiting· Phase 3
Test of an experimental drug for severe viral lung infection (ARDS)

This study tests an experimental drug (STSA-1002) for people with severe breathing problems caused by a viral infection. It aims to see if the drug can help improve oxygen levels and reduce the need for a breathing machine.

Beijing, Beijing Municipality
NCT07706855Not yet recruiting· Phase 1/Phase 2
Study of a new drug for serious lung failure from infection

This trial tests a new medicine called GKL-006RTU for people with moderate to severe ARDS caused by an infection. The goal is to see if it is safe and helps improve breathing and recovery.

NCT07779642Not yet recruiting· Phase 2
Personalized treatment for severe breathing failure

This trial tests two different medicines to see which one helps patients with severe breathing failure in the hospital. It aims to find the best treatment for each patient based on their condition.

NCT07588217Not yet recruiting· Phase 2/Phase 3
Ondansetron to prevent lung injury in patients on ventilators

This trial tests whether ondansetron, a medicine often used to prevent nausea, can also help prevent further lung damage in patients with a serious lung condition called ARDS who are on a breathing machine. If it works, it could help patients recover from severe breathing problems.

Montreal, Quebec
NCT07576660Recruiting· Phase 3
Dexamethasone for lung injury from sepsis

This trial tests whether the steroid dexamethasone can help people with sepsis who develop acute respiratory distress syndrome (ARDS), a severe lung injury. If you have an infection and need breathing support, this study may help find a better treatment.

Nanjing, Jiangsu

Hear when a new Nonintubated Acute Respiratory Distress Syndrome (ARDS) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.